Keynote: Pioneering the Future: Evolving Medical Affairs & Field Medical Strategy (Using Cell & Gene Therapies as a Case Study)

Session details:

As cell and gene therapies reshape treatment landscapes, Field Medical teams must adapt their approaches to meet the challenges of this unique space. This keynote will explore how traditional medical affairs strategies must shift to support the complexity, innovation, and specialized needs of novel therapies. Through a focused case study using the concept of cell and gene therapies, attendees will uncover practical considerations for team structure, stakeholder engagement, and strategic planning that align with the distinct dynamics rapidly evolving therapeutic modalities.

• Navigate the distinct planning considerations required for cell and gene therapies versus traditional small molecules.
• Identify new methods for HCP/KOL engagement, congress strategy and engagement, and insight collection tailored to
• the complexities of advanced therapies.
• Hear how successful field medical teams are structured and supported to thrive in the dynamic cell and gene environment.

Key Takeaways:

• Clear understanding of how novel therapies may require a unique approach to strategic and tactical field medical planning.
• Actionable ideas for refining external engagement strategies and educational tools in highly specialized therapeutic areas that are new to both manufacturers and health systems.
• Insight into the core competencies and success factors that drive high-performing medical affairs teams in this emerging space.